NC State enrolls Shelties in gallbladder mucocele genetics study
Bottom line
North Carolina State University’s College of Veterinary Medicine has opened enrollment for a genetics study aimed at identifying the underlying cause of gallbladder mucocele formation in Shetland Sheepdogs. The one-time study, led by Jody Gookin, is collecting DNA by blood sample, preferably, or cheek swab from eligible Shelties. The effort builds on years of NC State work on this disease, which the university describes as a prevalent and often deadly gallbladder disorder in dogs, and on prior research linking gallbladder mucocele formation to both breed risk and biologic pathways involving abnormal mucus production and CFTR dysfunction. (cvm.ncsu.edu)
Why it matters: For veterinary professionals, the study signals that investigators are moving beyond describing gallbladder mucocele formation and toward identifying breed-specific risk factors that may eventually support earlier screening, sharper risk stratification, and better client counseling for pet parents of Shetland Sheepdogs. That matters because gallbladder mucocele formation has emerged over the past two decades as the most common biliary disease in dogs, is seen disproportionately in older, small purebred dogs, and still carries meaningful short-term mortality even when treated surgically with cholecystectomy. (pubmed.ncbi.nlm.nih.gov)
What to watch: Watch for details on enrollment targets, any genome-wide association findings in Shetland Sheepdogs, and whether the work feeds into broader AKC Canine Health Foundation-funded research running through January 31, 2027. (akcchf.org)
North Carolina State University’s College of Veterinary Medicine is now enrolling Shetland Sheepdogs in a genetics study designed to identify the underlying cause of gallbladder mucocele formation, a serious biliary disease that has become a major focus of canine internal medicine research. According to the study description, eligible dogs will provide a one-time DNA sample, ideally by blood draw, or by cheek swab, along with limited signalment information. (cvm.ncsu.edu)
The announcement lands in the middle of a longer research arc led by Jody Gookin’s group at NC State. The lab says it has spent the past decade studying the pathogenesis of gallbladder mucocele formation, which it describes as a newly emergent, prevalent, and deadly dysfunction of the canine gallbladder epithelium. In a 2025 review in the Journal of the American Veterinary Medical Association, Gookin and colleagues wrote that the disease has emerged over the past 20 years and is now the most common biliary disease in dogs. (cvm.ncsu.edu)
That background helps explain why a Sheltie-focused genetics study matters. Shetland Sheepdogs have long been recognized as a high-risk breed, and earlier work identified a significant association between gallbladder mucocele diagnosis and an insertion mutation in ABCB4 in affected Shelties and some other breeds. In that study, 14 of 15 affected Shetland Sheepdogs carried the mutation, compared with 1 of 21 unaffected Shelties sampled. But the newer research direction suggests the story is more complicated than a single mutation. A 2024 NC State-led paper reported that dogs with gallbladder mucocele formation did not have cystic fibrosis-causing mutations in CFTR, but instead appeared to have acquired CFTR dysfunction, raising the possibility that multiple genes, environmental exposures, or both may be involved. (comparative-hepatology.biomedcentral.com)
That broader hypothesis is also reflected in active AKC Canine Health Foundation funding. An AKC CHF grant to Gookin running from February 1, 2025, through January 31, 2027, is explicitly studying how genetics, environmental exposures, and the enteric nervous system may influence gallbladder mucocele formation in dogs. The grant summary says one aim is a genome-wide association study focused on the breed at greatest risk in the U.S., which aligns closely with the newly announced Shetland Sheepdog enrollment effort. Additional aims include identifying environmental contaminants in gallbladder tissue and assessing early nerve injury in the gallbladder. (akcchf.org)
Industry and institutional messaging around the disease has also become more urgent. In AKC Canine Health Foundation materials, Gookin described becoming passionate about the condition because it affects older dogs that can become acutely, severely ill, and because the surgery needed to save them is expensive and carries high mortality. That concern is consistent with the 2025 JAVMA review, which states that definitive treatment is cholecystectomy and that while long-term prognosis can be good, short-term mortality remains significant. The AKC CHF grant summary quantifies that risk, noting that 17% of dogs do not survive even with surgery. (akcchf.org)
Why it matters: For veterinarians, this is less about a single enrollment notice and more about where the field is heading. Gallbladder mucocele formation has been clinically recognizable for years on ultrasound, and internists already know the common pattern: older, small purebred dogs, often with concurrent endocrinopathies or hyperlipidemia, presenting before obstruction or rupture if they’re fortunate. What remains missing is a reliable way to identify which apparently healthy at-risk dogs are most likely to progress. If this Sheltie study helps clarify inherited susceptibility, it could eventually influence screening recommendations, breeding discussions, and how primary care veterinarians counsel pet parents when incidental gallbladder changes first appear. (pubmed.ncbi.nlm.nih.gov)
It could also sharpen the profession’s understanding of whether gallbladder mucocele formation is best thought of as a classic inherited disorder, a multifactorial disease with environmental triggers, or a syndrome with several biologic pathways that converge on the same gallbladder phenotype. That distinction matters for diagnostics and prevention. A single high-penetrance mutation would support targeted testing; a more complex model would push the field toward combined genomic, metabolic, and exposure-based risk assessment. The current NC State and AKC CHF research program suggests investigators increasingly favor that more complex explanation. (akcchf.org)
What to watch: The next milestones are likely to be recruitment updates from NC State, clarification of inclusion criteria and sample size, and, longer term, whether the Sheltie cohort yields genome-wide association signals strong enough to translate into clinical screening tools before the AKC CHF grant period ends in January 2027. (akcchf.org)